| General Information | |||
|---|---|---|---|
| Term | congenital bile acid synthesis defect 1 | ID (Ontology) | DOID:0111071 (Human Disease) |
| Definition | A congenital bile acid synthesis defect characterized by progressive cholestatic liver disease, giant cell hepatitis, malabsorption of fat and fat-soluble vitamins, increased serum bilirubin and decreased serum cholesterol that has_material_basis_in homozygous or compound heterozygous mutation in the HSD3B7 gene on chromosome 16p. | ||
| Also Known As | "CBAS1" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
physical disorder_____________________ steroid inherited metabolic disorder__| congenital bile acid synthesis defect |__congenital bile acid synthesis defect 1 1 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | congenital bile acid synthesis defect | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:9813 MESH:C535442 MIM:607765 ORDO:79301 SNOMEDCT_US_2023_03_01:238033007 UMLS_CUI:C1843116 |
|||